Symmetrical bis-quinolinium compounds: new human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2005-04-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM049061OPMID 15857141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Oncogene].

  2019cited by this paper
• Towards a model for the inhibition of choline kinase by a new type of inhibitor.

  2005cited by this paper
• Influence of the linker in bispyridium compounds on the inhibition of human choline kinase.

  2004cited by this paper
• QSAR-derived choline kinase inhibitors: how rational can antiproliferative drug design be?

  2003cited by this paper
• Conformational dynamics of a bispyridinium cyclophane.

  2003cited by this paper
• Choline kinase inhibitory effect and antiproliferative activity of new 1,1',1"-(benzene-1,3,5-triylmethylene)tris[4-[(disubstituted)amino]pyridinium] tribromides.

  2003cited by this paper
• Choline Kinase Inhibitory Effect and Antiproliferative Activity of New 1,1′,1′′‐(Benzene‐1,3,5‐triylmethylene)tris{4‐ [(disubstituted)amino]pyridinium} Tribromides.

  2003cited by this paper
• Bispyridinium cyclophanes: novel templates for human choline kinase inhibitors.

  2003cited by this paper
• Quantitative structure-activity relationships for a series of symmetrical bisquaternary anticancer compounds.

  2002cited by this paper
• Regulation of choline kinase activity by Ras proteins involves Ral–GDS and PI3K

  2002cited by this paper
• Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers.

  2002cited by this paper
• Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy

  2002cited by this paper
• LUMO energy of model compounds of bispyridinium compounds as an index for the inhibition of choline kinase.

  2001cited by this paper
• Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity

  2001cited by this paper
• Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells.

  2001cited by this paper
• QSAR of 1,1'-(1,2-ethylenebisbenzyl)bis(4-substitutedpyridinium) dibromides as choline kinase inhibitors: a different approach for antiproliferative drug design.

  2000cited by this paper
• Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth.

  1999cited by this paper
• In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery.

  1999cited by this paper
• Synthesis and Antibacterial Activity of New 4-Alkoxy-, 4-Aminoalkyl-, and 4-Alkylthioquinoline Derivatives.

  1998cited by this paper
• Choline kinase inhibitors as a novel approach for antiproliferative drug design

  1997cited by this paper
• Synthesis, molecular modeling, and K+ channel-blocking activity of dequalinium analogues having semirigid linkers.

  1996cited by this paper
• Mutations of ras genes in human tumors (review).

  1995cited by this paper
• Generation of phosphorylcholine as an essential event in the activation of Raf‐1 and MAP‐kinases in growth factors‐induced mitogenic stimulation

  1995cited by this paper
• Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines.

  1995cited by this paper
• Manual of oncologic therapeutics

  1995cited by this paper
• Synthesis and quantitative structure-activity relationships of dequalinium analogues as K+ channel blockers: investigation into the role of the substituent at position 4 of the quinoline ring.

  1995cited by this paper
• Signal transduction pathways involving Ras. Mini review.

  1994cited by this paper
• p21 Ras as a governor of global gene expression.

  1994cited by this paper
• QSAR : Hansch analysis and related approaches

  1993cited by this paper
• Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors.

  1993cited by this paper
• In vivo 31P MRS of experimental tumours

  1993cited by this paper
• Phospholipid metabolites, prognosis and proliferation in human breast carcinoma

  1993cited by this paper
• Phospholipid metabolites as indicators of cancer cell function

  1992cited by this paper
• Comprehensive medicinal chemistry

  1991cited by this paper
• Manual of oncologic therapeutics

  1991cited by this paper
• ras oncogenes: their role in neoplasia

  1990cited by this paper
• Altered phosphatidylcholine metabolism in C3H10T1/2 cells transfected with the Harvey-ras oncogene.

  1990cited by this paper
• Regulation of phosphatidylcholine biosynthesis.

  1990cited by this paper
• Regulation of phosphatidylcholine biosynthesis

  1990cited by this paper
• Comprehensive medicinal chemistry : the rational design, mechanistic study & therapeutic application of chemical compounds

  1990cited by this paper
• Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics

  1989cited by this paper
• The Reaction of Activated Aryl and Heteroaryl Dihalides with Hmpa. A Regioselectivity Study

  1985cited by this paper
• Regulation of phosphatidylcholine biosynthesis.

  1984cited by this paper
• Substituent Constants for Correlation Analysis in Chemistry and Biology.

  1980cited by this paper
• A Convenient Synthesis of Methylamino and Dimethylamino Substituted Aromatic Compounds

  1980cited by this paper
• Chemische Struktur und biologische Aktivität von Wirkstoffen : Methoden der quantitativen Struktur-Wirkung-Analyse

  1979cited by this paper
• Quantitative drug design

  1978cited by this paper
• Synthesis of Naphthyridines

  1975cited by this paper
• Biosynthesis of complex lipids.

  1961cited by this paper
• Konstitution und Eigenschaften des Biphenylen‐(4.4′)‐bis‐[methyl‐atropiniumbromids], einer biquartären Atropinverbindung

  1961cited by this paper
• BIS(BROMOMETHYL) COMPOUNDS

  1952cited by this paper
• Macro Rings. I. Preparation and Spectra of the Paracyclophanes

  1951cited by this paper
• RELATIVE EASE OF CYCLIZATION OF 2-, 3-, AND 4-AMINOPYRIDINE DERIVATIVES. SYNTHESIS OF NAPHTHYRIDINES1

  1950cited by this paper
• Substitutions at the alpha-or gamma-positions in pyridyl ring systems by basic reagents.

  1949cited by this paper
• 155. The action of phosphoryl chloride on the toluene-p-sulphonyl derivative of β-anilinopropionic acid

  1933cited by this paper

• Facile photocatalytic reactions in various conditions using quinolinium salts as photocatalysts

  2025cites this paper
• The role of phosphatidylcholine metabolism in tumors

  2025cites this paper
• Synthesis and Photolysis Properties of a New Chloroquine Photoaffinity Probe

  2024cites this paper
• Synthesis of green benzamide-decorated UiO-66-NH2 for biomedical applications.

  2022cites this paper
• Efficient Synthesis of 7 H ‐Chromeno[3,2‐c]quinolin‐5‐ium Salts and Quinolin‐4‐ones through Acid‐Promoted Cascade Reaction of 3‐Formylchromones and Anilines

  2022cites this paper
• Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors

  2022cites this paper
• History of Research on Phospholipid Metabolism and Applications to the Detection, Diagnosis, and Treatment of Cancer

  2022cites this paper
• Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines

  2022cites this paper
• Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases

  2021cites this paper
• Novel Non-Congeneric Derivatives of the Choline Kinase Alpha Inhibitor ICL-CCIC-0019

  2021cites this paper
• Down-regulation of Survivin and Bcl-2 concomitant with the activation of caspase-3 as a mechanism of apoptotic death in KG1a and K562 cells upon exposure to a derivative from ciprofloxacin family.

  2020cites this paper
• Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition

  2020cites this paper
• Synthesis of Quinolinium Salts from N -Substituted Anilines, Aldehydes, Alkynes, and Acids: Theoretical Understanding of the Mechanism and Regioselectivity

  2020cites this paper
• Synthesis of quinoline derivatives as potential cysteine protease inhibitors.

  2020cites this paper
• Rh(III)-Catalyzed C(8)-H Activation of Quinoline N-oxides: Regioselective C-Br and C-N Bond Formation.

  2019cites this paper
• Anti-proliferative activity, molecular modeling studies and interaction with calf thymus DNA of novel ciprofloxacin analogues

  2018cites this paper
• Methylamino- and dimethylaminoquinolines

  2018cites this paper
• A minimalistic approach to develop new anti-apicomplexa polyamines analogs.

  2018cites this paper
• EB‐3D a novel choline kinase inhibitor induces deregulation of the AMPK‐mTOR pathway and apoptosis in leukemia T‐cells

  2018cites this paper
• Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors.

  2018cites this paper
• Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities

  2017cites this paper
• Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors

  2017cites this paper
• Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1)

  2016cites this paper
• Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.

  2016cites this paper
• Synthesis of 3-Sulfonylamino Quinolines from 1-(2-Aminophenyl) Propargyl Alcohols through a Ag(I)-Catalyzed Hydroamination, (2 + 3) Cycloaddition, and an Unusual Strain-Driven Ring Expansion.

  2015cites this paper
• p-Nitrobenzenesulfonamides and their fluorescent dansylsulfonamides derived from N-alkylated o-(purine-methyl)anilines as novel antitumour agents

  2015cites this paper
• New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1.

  2015cites this paper
• Hnf4α and Choline Metabolism Role in β-catenin Activated Liver Carcinogenesis

  2015cites this paper
• Pharmacophore‐Based Virtual Screening to Discover New Active Compounds for Human Choline Kinase α1

  2015cites this paper
• Preclinical Characterization of RSM-932A, a Novel Anticancer Drug Targeting the Human Choline Kinase Alpha, an Enzyme Involved in Increased Lipid Metabolism of Cancer Cells

  2014cites this paper
• Direct Inhibition of Choline Kinase by a Near-Infrared Fluorescent Carbocyanine

  2014cites this paper
• A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products

  2014cites this paper
• Synthesis, Antimicrobial and Molecular Docking Studies of Benzimidazole and Benzotriazole based Dicationic Sulphonophanes

  2014cites this paper
• Synthesis of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines.

  2013cites this paper
• New non-symmetrical choline kinase inhibitors.

  2013cites this paper
• Antiplasmodial Activity and Mechanism of Action of RSM-932A, a Promising Synergistic Inhibitor of Plasmodium falciparum Choline Kinase

  2013cites this paper
• Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.

  2013cites this paper
• New Green Synthesis and Antineoplastic Activity of Bis (3-Arylimidazolidinyl-1) Methanes

  2013cites this paper
• Preparation of N-phenylbenzo[h]quinolinium derivatives labeled with tritium

  2012cites this paper
• Arylation of adamantanamines: IV. Palladium-catalyzed arylation of amines of adamantane series with isomeric chloroquinolines

  2012cites this paper
• Milk fat globule membrane – a source of polar lipids for colon health? A review

  2012cites this paper
• Novel 4‐Amino Bis‐pyridinium and Bis‐quinolinium Derivatives as Choline Kinase Inhibitors with Antiproliferative Activity against the Human Breast Cancer SKBR‐3 Cell Line

  2012cites this paper
• Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors.

  2012cites this paper
• Investigations of the health benefits of buttermilk fat globule membrane lipid components

  2011cites this paper
• Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivity.

  2011cites this paper
• Synthesis and biological activity of new bispyridinium salts of 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazoles.

  2011cites this paper
• Novel Library of Selenocompounds as Kinase Modulators

  2011cites this paper
• Basic alumina supported one-pot synthesis of structurally diverse pyridine/quinolinine-fused novel diazepanium, diazocanium, imidazodilinium and tetrahydro-pyrimidiniums

  2011cites this paper
• 7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.

  2009cites this paper
• Potential choline kinase inhibitors: a molecular modeling study of bis-quinolinium compounds.

  2009influential citation
• Insight into the Inhibition of Human Choline Kinase: Homology Modeling and Molecular Dynamics Simulations

  2006cites this paper
• Synthesis and Biological Activity of Novel Symmetrical Bis-2-phenyliminothiazolidine Derivatives

  2006cites this paper
• (Q)SAR studies to design new human choline kinase inhibitors as antiproliferative drugs.

  2006cites this paper
• 1H and 13C spectral assignment of symmetrical bis[(4‐aminosubstituted)quinolinium] derivatives

  2005cites this paper